Skip to main content

Odonate Therapeutics, Inc.

ODTDelisted Jan 25, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001717452

Odonate Therapeutics, Inc. was delisted on Jan 25, 2022; its insiders filed their last Form 4 on Dec 10, 2021; 50 institutions reported holding it in 13F filings for Q4 2021, worth $32.7M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in Odonate Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

ODT is no longer listed, and 13F filings after Q4 2021 list far fewer holders. See Q4 2021

Institutional holders
0
−8 vs. Q1 2022
Shares held
0
−5.41M (−100.0%) vs. Q1 2022
Total value
$0
−$7.13M (−100.0%) vs. Q1 2022
New holders
0
0 more added
Sold out
8
0 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ODT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 0 institutions
Q1 2021: 83 institutionsQ2 2021: 69 institutionsQ3 2021: 58 institutionsQ4 2021: 50 institutionsQ1 2022: 8 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $0
Q1 2021: $111.6MQ2 2021: $115.0MQ3 2021: $94.9MQ4 2021: $32.7MQ1 2022: $7.13MQ2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ODT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20228$7.13M
Q4 202150$32.7M
Q3 202158$94.9M
Q2 202169$115.0M
Q1 202183$111.6M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Odonate Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding ODT in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Boxer Capital, LLC0$00.00%−4,207,086−100.0%Sold out
Samsara BioCapital, LLC0$00.00%−700,421−100.0%Sold out
Acadian Asset Management LLC0$00.00%−384,995−100.0%Sold out
Hennion & Walsh Asset Management, Inc.0$00.00%−69,264−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−43,752−100.0%Sold out
Simplex Trading, LLC0$00.00%−2,000−100.0%Sold out
Bessemer Group Inc0$00.00%−230−100.0%Sold out
Newbridge Financial Services Group, Inc.0$00.00%−47−100.0%Sold out